Padlock Therapeutics padlocktherapeutics.com


Public lists: Pharma Startups (4734)

Padlock Therapeutics is a private, Cambridge, Massachusetts-based biotechnology company dedicated to creating new medicines to treat destructive autoimmune diseases. The company leverages the science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes.

Padlock Therapeutics is a private, Cambridge, Massachusetts-based biotechnology company dedicated to creating new medicines to treat destructive autoimmune diseases. The company leverages the science on the role of protein citrullination in disease t...Show all

Company (Acquired)

Phone: 978-381-9601

Fax:

200 Cambridge Park Drive

Cambridge, 02140
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Padlock Therapeutics $23M Mar 23, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Padlock Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Atlas VentureVenture CapitalCambridge, Massachusetts, United StatesSeries A
Index VenturesVenture CapitalLondon, England, United Kingdom
Johnson & JohnsonCorporationNew Brunswick, New Jersey, United States
Johnson & Johnson InnovationCorporate VentureCambridge, Massachusetts, United StatesSeries A
JLabsIncubator/AcceleratorSan Diego, California, United StatesIncubator/Accelerator
See all 8 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Bicyclic inhibitors of pad4 Dec 09, 2016 May 08, 2018 Patent
Aza-benzimidazole inhibitors of pad4 Dec 09, 2016 Sep 19, 2017 Patent